These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. [Screening for adenocarcinoma in Barrett's esophagus: yes or no, when and how?]. Sostres C; Lacarta P; Lanas A Gastroenterol Hepatol; 2013 Oct; 36(8):520-6. PubMed ID: 23453559 [TBL] [Abstract][Full Text] [Related]
16. How far to go? Screening and surveillance in Barrett's esophagus. Lieberman DA; Sampliner RE Am J Manag Care; 2001 Feb; 7(1 Suppl):S19-26. PubMed ID: 11225349 [TBL] [Abstract][Full Text] [Related]
17. The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma. Brabender J; Marjoram P; Lord RV; Metzger R; Salonga D; Vallböhmer D; Schäfer H; Danenberg KD; Danenberg PV; Selaru FM; Baldus SE; Hölscher AH; Meltzer SJ; Schneider PM Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2113-7. PubMed ID: 16172218 [TBL] [Abstract][Full Text] [Related]
18. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. Cameron AJ; Ott BJ; Payne WS N Engl J Med; 1985 Oct; 313(14):857-9. PubMed ID: 4033716 [TBL] [Abstract][Full Text] [Related]
19. Barrett's oesophagus and carcinoma. Recent insights into its development and possible prevention. Peters FT; Kleibeuker JH Scand J Gastroenterol Suppl; 1993; 200():59-64. PubMed ID: 8016573 [TBL] [Abstract][Full Text] [Related]